[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Tuesday, 4 July 2006, 15:30 GMT 16:30 UK
Drug maker files for insolvency
Parexel, the firm which carried out the trials of TGN1412
Parexel carried out the trial for TeGenero
The German firm that produced a drug at the heart of a disastrous clinical trial that left six men seriously ill has declared itself insolvent.

TeGenero, a German pharmaceutical company, said it could not continue in business.

Because of the fallout from the UK trial, it was impossible to attract investment, TeGenero said.

Claims for compensation arising from the trial will continue to be handled by TeGenero's insurers.

Parexel, a clinical research organisation, carried out the trial on behalf of TeGenero.

Six previously healthy men who took part in the trial of the drug, TGN1412, suffered multiple organ failure.

The Medicines and Healthcare products Regulatory Authority (MHRA) said Parexel failed to follow proper procedures.

It found there was also no contract in place between TeGenero, the makers of the drug, and Parexel at the beginning of the trial.

TeGenero has maintained that the men's reactions were "completely unexpected" and did not reflect the results obtained from the earlier laboratory studies.

A recap on the drugs trial that went wrong

The BBC is not responsible for the content of external internet sites

Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit


Americas Africa Europe Middle East South Asia Asia Pacific